SIMILAR PATTERNS OF AMINO ACIDS FOR 4PM5_A_CE3A301

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1alq CP254 BETA-LACTAMASE

(Staphylococcus
aureus) 		PF13354
(Beta-lactamase2) 		6 TYR A 105
SER A 130
ASN A 132
ASN A 170
LYS A 234
GLY A 236
 None
 0.81A 4pm5A-1alqA:
28.0		 4pm5A-1alqA:
30.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1bsg BETA LACTAMASE

(Streptomyces
albus) 		PF13354
(Beta-lactamase2) 		7 ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
GLY A 238
 None
 0.32A 4pm5A-1bsgA:
42.6		 4pm5A-1bsgA:
46.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1bsg BETA LACTAMASE

(Streptomyces
albus) 		PF13354
(Beta-lactamase2) 		7 SER A 130
ASN A 132
ASN A 170
LYS A 234
THR A 235
GLY A 236
GLY A 238
 None
 0.61A 4pm5A-1bsgA:
42.6		 4pm5A-1bsgA:
46.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1bue PROTEIN
(IMIPENEM-HYDROLYSIN
G BETA-LACTAMASE)

(Enterobacter
cloacae) 		PF13354
(Beta-lactamase2) 		6 ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
 None
 0.67A 4pm5A-1bueA:
40.5		 4pm5A-1bueA:
49.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1bue PROTEIN
(IMIPENEM-HYDROLYSIN
G BETA-LACTAMASE)

(Enterobacter
cloacae) 		PF13354
(Beta-lactamase2) 		6 ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
SER A 237
 None
 0.72A 4pm5A-1bueA:
40.5		 4pm5A-1bueA:
49.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1bue PROTEIN
(IMIPENEM-HYDROLYSIN
G BETA-LACTAMASE)

(Enterobacter
cloacae) 		PF13354
(Beta-lactamase2) 		6 SER A 130
ASN A 132
ASN A 170
LYS A 234
THR A 235
GLY A 236
 None
 0.90A 4pm5A-1bueA:
40.5		 4pm5A-1bueA:
49.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1bue PROTEIN
(IMIPENEM-HYDROLYSIN
G BETA-LACTAMASE)

(Enterobacter
cloacae) 		PF13354
(Beta-lactamase2) 		6 SER A 130
ASN A 170
LYS A 234
THR A 235
GLY A 236
SER A 237
 None
 0.99A 4pm5A-1bueA:
40.5		 4pm5A-1bueA:
49.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1dy6 CARBAPENEM-HYDROLYSI
NG BETA-LACTAMASE
SME-1

(Serratia
marcescens) 		PF13354
(Beta-lactamase2) 		6 ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
 None
 0.60A 4pm5A-1dy6A:
41.1		 4pm5A-1dy6A:
48.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1dy6 CARBAPENEM-HYDROLYSI
NG BETA-LACTAMASE
SME-1

(Serratia
marcescens) 		PF13354
(Beta-lactamase2) 		6 ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 239
 None
 0.90A 4pm5A-1dy6A:
41.1		 4pm5A-1dy6A:
48.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1dy6 CARBAPENEM-HYDROLYSI
NG BETA-LACTAMASE
SME-1

(Serratia
marcescens) 		PF13354
(Beta-lactamase2) 		6 ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
SER A 237
 None
 0.70A 4pm5A-1dy6A:
41.1		 4pm5A-1dy6A:
48.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1dy6 CARBAPENEM-HYDROLYSI
NG BETA-LACTAMASE
SME-1

(Serratia
marcescens) 		PF13354
(Beta-lactamase2) 		6 SER A 130
ASN A 132
ASN A 170
LYS A 234
THR A 235
GLY A 236
 None
 0.86A 4pm5A-1dy6A:
41.1		 4pm5A-1dy6A:
48.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1dy6 CARBAPENEM-HYDROLYSI
NG BETA-LACTAMASE
SME-1

(Serratia
marcescens) 		PF13354
(Beta-lactamase2) 		6 SER A 130
ASN A 132
ASN A 170
LYS A 234
THR A 235
GLY A 239
 None
 1.04A 4pm5A-1dy6A:
41.1		 4pm5A-1dy6A:
48.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1dy6 CARBAPENEM-HYDROLYSI
NG BETA-LACTAMASE
SME-1

(Serratia
marcescens) 		PF13354
(Beta-lactamase2) 		6 SER A 130
ASN A 170
LYS A 234
THR A 235
GLY A 236
SER A 237
 None
 0.97A 4pm5A-1dy6A:
41.1		 4pm5A-1dy6A:
48.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e25 EXTENDED-SPECTRUM
BETA-LACTAMASE PER-1

(Pseudomonas
aeruginosa) 		PF13354
(Beta-lactamase2) 		6 SER A 130
ASN A 132
THR A 216
LYS A 234
THR A 235
GLY A 236
 SO4  A 500 (-2.6A)
None
SO4  A 500 ( 4.0A)
SO4  A 500 (-3.2A)
SO4  A 500 (-3.8A)
SO4  A 500 (-3.5A)
 0.63A 4pm5A-1e25A:
32.5		 4pm5A-1e25A:
29.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1g68 BETA-LACTAMASE PSE-4

(Pseudomonas
aeruginosa) 		PF13354
(Beta-lactamase2) 		6 TYR A 105
SER A 130
ASN A 132
ASN A 170
GLY A 236
GLY A 238
 None
SO4  A 400 (-2.7A)
None
None
SO4  A 400 (-3.0A)
None
 0.47A 4pm5A-1g68A:
39.4		 4pm5A-1g68A:
39.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hzo BETA-LACTAMASE

(Proteus
vulgaris) 		PF13354
(Beta-lactamase2) 		9 TYR A 105
ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
SER A 237
GLY A 238
 MES  A1000 (-3.9A)
None
None
MES  A1000 (-3.7A)
MES  A1000 (-2.9A)
MES  A1000 (-3.7A)
MES  A1000 (-3.1A)
MES  A1000 (-2.7A)
None
 0.53A 4pm5A-1hzoA:
46.7		 4pm5A-1hzoA:
65.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hzo BETA-LACTAMASE

(Proteus
vulgaris) 		PF13354
(Beta-lactamase2) 		9 TYR A 105
SER A 130
ASN A 132
ASN A 170
LYS A 234
THR A 235
GLY A 236
SER A 237
GLY A 238
 MES  A1000 (-3.9A)
MES  A1000 (-2.7A)
None
None
MES  A1000 (-2.9A)
MES  A1000 (-3.7A)
MES  A1000 (-3.1A)
MES  A1000 (-2.7A)
None
 0.74A 4pm5A-1hzoA:
46.7		 4pm5A-1hzoA:
65.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1i2w BETA-LACTAMASE

(Bacillus
licheniformis) 		PF13354
(Beta-lactamase2) 		8 ASN A 104
TYR A 105
ASN A 132
THR A 216
LYS A 234
THR A 235
GLY A 236
GLY A 238
 CFX  A1300 (-3.9A)
CFX  A1300 ( 4.9A)
CFX  A1300 (-3.0A)
CFX  A1300 (-3.2A)
CFX  A1300 ( 3.9A)
CFX  A1300 (-3.6A)
CFX  A1300 (-3.3A)
CFX  A1300 ( 4.1A)
 0.40A 4pm5A-1i2wA:
41.2		 4pm5A-1i2wA:
42.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1i2w BETA-LACTAMASE

(Bacillus
licheniformis) 		PF13354
(Beta-lactamase2) 		8 ASN A 104
TYR A 105
SER A 130
ASN A 132
LYS A 234
THR A 235
GLY A 236
GLY A 238
 CFX  A1300 (-3.9A)
CFX  A1300 ( 4.9A)
CFX  A1300 (-3.1A)
CFX  A1300 (-3.0A)
CFX  A1300 ( 3.9A)
CFX  A1300 (-3.6A)
CFX  A1300 (-3.3A)
CFX  A1300 ( 4.1A)
 0.61A 4pm5A-1i2wA:
41.2		 4pm5A-1i2wA:
42.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j9m DD-TRANSPEPTIDASE

(Streptomyces
sp. K15) 		PF00768
(Peptidase_S11) 		6 SER A  96
LYS A 213
THR A 214
GLY A 215
SER A 216
GLY A 217
 NA  A 600 (-3.1A)
NA  A 600 (-3.4A)
NA  A 600 (-3.9A)
NA  A 600 ( 3.6A)
CL  A 601 (-3.0A)
None
 0.61A 4pm5A-1j9mA:
22.0		 4pm5A-1j9mA:
27.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j9m DD-TRANSPEPTIDASE

(Streptomyces
sp. K15) 		PF00768
(Peptidase_S11) 		6 THR A 199
LYS A 213
THR A 214
GLY A 215
SER A 216
GLY A 217
 NA  A 600 ( 4.5A)
NA  A 600 (-3.4A)
NA  A 600 (-3.9A)
NA  A 600 ( 3.6A)
CL  A 601 (-3.0A)
None
 0.30A 4pm5A-1j9mA:
22.0		 4pm5A-1j9mA:
27.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1n4o L2 BETA-LACTAMASE

(Stenotrophomonas
maltophilia) 		PF13354
(Beta-lactamase2) 		8 SER A 130
ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
SER A 237
 SO4  A1002 (-3.1A)
None
None
SO4  A1002 ( 4.8A)
SO4  A1002 (-3.6A)
SO4  A1002 (-3.6A)
SO4  A1002 (-3.2A)
SO4  A1002 (-2.7A)
 0.61A 4pm5A-1n4oA:
40.4		 4pm5A-1n4oA:
47.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1n9b BETA-LACTAMASE SHV-2

(Klebsiella
pneumoniae) 		PF13354
(Beta-lactamase2) 		7 TYR A 105
SER A 130
ASN A 132
ASN A 170
LYS A 234
THR A 235
GLY A 236
 EPE  A 400 (-3.6A)
EPE  A 400 (-2.5A)
None
None
EPE  A 400 (-3.1A)
EPE  A 400 (-3.8A)
EPE  A 400 (-3.1A)
 0.42A 4pm5A-1n9bA:
35.6		 4pm5A-1n9bA:
39.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1w5d PENICILLIN-BINDING
PROTEIN

(Bacillus
subtilis) 		PF02113
(Peptidase_S13) 		5 ASN A 301
THR A 394
LYS A 411
THR A 412
GLY A 413
 None
 0.31A 4pm5A-1w5dA:
21.0		 4pm5A-1w5dA:
22.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1zg4 BETA-LACTAMASE TEM

(Escherichia
coli) 		PF13354
(Beta-lactamase2) 		7 TYR A 105
SER A 130
ASN A 132
ASN A 170
LYS A 234
GLY A 236
GLY A 238
 None
 0.72A 4pm5A-1zg4A:
38.3		 4pm5A-1zg4A:
38.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c6w PENICILLIN-BINDING
PROTEIN 1A

(Streptococcus
pneumoniae) 		PF00905
(Transpeptidase) 		6 SER B 428
ASN B 430
THR B 543
LYS B 557
THR B 558
GLY B 559
 CL  B 704 (-3.4A)
None
CL  B 704 ( 4.8A)
None
CL  B 704 (-4.5A)
CL  B 704 ( 4.0A)
 0.69A 4pm5A-2c6wB:
17.0		 4pm5A-2c6wB:
22.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2cc1 BETA-LACTAMASE

(Mycolicibacterium
fortuitum) 		PF13354
(Beta-lactamase2) 		6 SER A 130
ASN A 105
THR A 235
GLY A 236
SER A 237
GLY A 238
 None
 1.45A 4pm5A-2cc1A:
40.7		 4pm5A-2cc1A:
44.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2cc1 BETA-LACTAMASE

(Mycolicibacterium
fortuitum) 		PF13354
(Beta-lactamase2) 		8 SER A 130
ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
GLY A 238
 None
 0.56A 4pm5A-2cc1A:
40.7		 4pm5A-2cc1A:
44.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2cc1 BETA-LACTAMASE

(Mycolicibacterium
fortuitum) 		PF13354
(Beta-lactamase2) 		8 SER A 130
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
SER A 237
GLY A 238
 None
 0.72A 4pm5A-2cc1A:
40.7		 4pm5A-2cc1A:
44.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fff PENICILLIN-BINDING
PROTEIN 1B

(Streptococcus
pneumoniae) 		PF00905
(Transpeptidase) 		6 TYR B 498
ASN B 518
THR B 629
LYS B 651
THR B 652
GLY B 653
 None
 0.60A 4pm5A-2fffB:
17.0		 4pm5A-2fffB:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fff PENICILLIN-BINDING
PROTEIN 1B

(Streptococcus
pneumoniae) 		PF00905
(Transpeptidase) 		6 TYR B 498
SER B 516
ASN B 518
LYS B 651
THR B 652
GLY B 653
 None
 0.74A 4pm5A-2fffB:
17.0		 4pm5A-2fffB:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iwb METHICILLIN
RESISTANCE MECR1
PROTEIN

(Staphylococcus
aureus) 		PF00905
(Transpeptidase) 		6 SER A 439
ASN A 441
LYS A 528
THR A 529
GLY A 530
GLY A 532
 GOL  A 604 (-2.6A)
GOL  A 605 (-2.8A)
GOL  A 604 (-2.9A)
GOL  A 604 (-3.7A)
GOL  A 605 ( 3.2A)
None
 0.64A 4pm5A-2iwbA:
19.4		 4pm5A-2iwbA:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jch PENICILLIN-BINDING
PROTEIN 1B

(Streptococcus
pneumoniae) 		PF00905
(Transpeptidase)
PF00912
(Transgly) 		7 TYR A 498
SER A 516
ASN A 518
THR A 629
LYS A 651
THR A 652
GLY A 653
 PL7  A1793 (-4.3A)
PL7  A1793 (-3.0A)
PL7  A1793 (-3.2A)
PL7  A1793 ( 4.1A)
PL7  A1793 ( 4.1A)
PL7  A1793 (-3.9A)
PL7  A1793 (-3.3A)
 0.83A 4pm5A-2jchA:
15.5		 4pm5A-2jchA:
17.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rdl CHYMASE 2

(Mesocricetus
auratus) 		PF00089
(Trypsin) 		6 GLY A 197
ASN A 189
THR A 229
GLY A 196
SER A 195
GLY A 193
 None
 1.46A 4pm5A-2rdlA:
undetectable		 4pm5A-2rdlA:
25.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2v2f PENICILLIN BINDING
PROTEIN 1A

(Streptococcus
pneumoniae) 		PF00905
(Transpeptidase) 		6 SER F 428
ASN F 430
THR F 543
LYS F 557
THR F 558
GLY F 559
 MES  F1653 (-3.1A)
None
MES  F1653 (-3.7A)
MES  F1653 ( 4.0A)
MES  F1653 (-3.8A)
MES  F1653 (-3.6A)
 0.65A 4pm5A-2v2fF:
17.9		 4pm5A-2v2fF:
24.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wae PENICILLIN-BINDING
PROTEIN 2B

(Streptococcus
pneumoniae) 		PF00905
(Transpeptidase)
PF03717
(PBP_dimer) 		6 SER A 443
ASN A 445
THR A 600
LYS A 615
THR A 616
GLY A 617
 None
 0.66A 4pm5A-2waeA:
16.0		 4pm5A-2waeA:
17.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2wyx BETA-LACTAMSE TOHO-1

(Escherichia
coli) 		PF13354
(Beta-lactamase2) 		10 ASN A 104
TYR A 105
ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
SER A 237
GLY A 238
 None
 0.48A 4pm5A-2wyxA:
46.0		 4pm5A-2wyxA:
83.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2wyx BETA-LACTAMSE TOHO-1

(Escherichia
coli) 		PF13354
(Beta-lactamase2) 		9 ASN A 104
TYR A 105
SER A 130
ASN A 132
LYS A 234
THR A 235
GLY A 236
SER A 237
GLY A 238
 None
 0.68A 4pm5A-2wyxA:
46.0		 4pm5A-2wyxA:
83.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2wyx BETA-LACTAMSE TOHO-1

(Escherichia
coli) 		PF13354
(Beta-lactamase2) 		7 GLY A 236
ASN A 104
TYR A 105
ASN A 170
THR A 216
LYS A 234
GLY A 238
 None
 1.44A 4pm5A-2wyxA:
46.0		 4pm5A-2wyxA:
83.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a3i PENICILLIN-BINDING
PROTEIN 4

(Haemophilus
influenzae) 		PF02113
(Peptidase_S13) 		6 ASN A 312
THR A 401
LYS A 420
THR A 421
GLY A 422
SER A 423
 AIX  A 501 (-3.3A)
AIX  A 501 ( 4.0A)
AIX  A 501 ( 3.8A)
AIX  A 501 (-3.4A)
AIX  A 501 (-3.4A)
AIX  A 501 (-2.5A)
 0.70A 4pm5A-3a3iA:
20.6		 4pm5A-3a3iA:
21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a3i PENICILLIN-BINDING
PROTEIN 4

(Haemophilus
influenzae) 		PF02113
(Peptidase_S13) 		6 SER A 310
ASN A 312
LYS A 420
THR A 421
GLY A 422
SER A 423
 AIX  A 501 (-2.8A)
AIX  A 501 (-3.3A)
AIX  A 501 ( 3.8A)
AIX  A 501 (-3.4A)
AIX  A 501 (-3.4A)
AIX  A 501 (-2.5A)
 0.91A 4pm5A-3a3iA:
20.6		 4pm5A-3a3iA:
21.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3bfg CLASS A
BETA-LACTAMASE SED1

(Citrobacter
sedlakii) 		PF13354
(Beta-lactamase2) 		7 ASN A 104
ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
 MER  A 301 ( 4.1A)
MER  A 301 (-3.2A)
MER  A 301 (-2.6A)
MER  A 301 (-3.6A)
MER  A 301 (-3.2A)
MER  A 301 (-3.5A)
MER  A 301 (-3.0A)
 0.43A 4pm5A-3bfgA:
46.9		 4pm5A-3bfgA:
75.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3bfg CLASS A
BETA-LACTAMASE SED1

(Citrobacter
sedlakii) 		PF13354
(Beta-lactamase2) 		7 ASN A 104
SER A 130
ASN A 132
ASN A 170
LYS A 234
THR A 235
GLY A 236
 MER  A 301 ( 4.1A)
MER  A 301 (-2.6A)
MER  A 301 (-3.2A)
MER  A 301 (-2.6A)
MER  A 301 (-3.2A)
MER  A 301 (-3.5A)
MER  A 301 (-3.0A)
 0.66A 4pm5A-3bfgA:
46.9		 4pm5A-3bfgA:
75.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3byd BETA-LACTAMASE OXY-1

(Klebsiella
oxytoca) 		PF13354
(Beta-lactamase2) 		7 ASN A 135
ASN A 173
THR A 219
LYS A 237
THR A 238
GLY A 239
GLY A 241
 None
None
SO4  A 301 ( 4.0A)
SO4  A 301 (-3.1A)
SO4  A 301 (-3.9A)
SO4  A 301 (-3.3A)
None
 0.29A 4pm5A-3bydA:
47.3		 4pm5A-3bydA:
74.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3byd BETA-LACTAMASE OXY-1

(Klebsiella
oxytoca) 		PF13354
(Beta-lactamase2) 		7 SER A 133
ASN A 135
ASN A 173
LYS A 237
THR A 238
GLY A 239
GLY A 241
 SO4  A 301 (-2.8A)
None
None
SO4  A 301 (-3.1A)
SO4  A 301 (-3.9A)
SO4  A 301 (-3.3A)
None
 0.61A 4pm5A-3bydA:
47.3		 4pm5A-3bydA:
74.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dwk PENICILLIN-BINDING
PROTEIN 2

(Staphylococcus
aureus) 		PF00905
(Transpeptidase)
PF00912
(Transgly) 		6 SER A 454
ASN A 456
LYS A 583
THR A 584
GLY A 585
GLY A 587
 SO4  A  26 (-3.1A)
None
SO4  A  26 ( 4.2A)
SO4  A  26 (-3.6A)
SO4  A  26 (-3.3A)
None
 0.81A 4pm5A-3dwkA:
18.3		 4pm5A-3dwkA:
18.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dwz BETA-LACTAMASE

(Mycobacterium
tuberculosis) 		PF13354
(Beta-lactamase2) 		6 ASN A 186
THR A 232
LYS A 250
THR A 251
GLY A 252
GLY A 254
 DWZ  A 400 ( 4.0A)
DWZ  A 400 ( 4.5A)
DWZ  A 400 ( 3.8A)
DWZ  A 400 (-3.5A)
DWZ  A 400 (-3.3A)
None
 0.34A 4pm5A-3dwzA:
41.1		 4pm5A-3dwzA:
45.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dwz BETA-LACTAMASE

(Mycobacterium
tuberculosis) 		PF13354
(Beta-lactamase2) 		6 SER A 142
ASN A 186
LYS A 250
THR A 251
GLY A 252
GLY A 254
 DWZ  A 400 (-2.7A)
DWZ  A 400 ( 4.0A)
DWZ  A 400 ( 3.8A)
DWZ  A 400 (-3.5A)
DWZ  A 400 (-3.3A)
None
 0.62A 4pm5A-3dwzA:
41.1		 4pm5A-3dwzA:
45.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3lez BETA-LACTAMASE

(Oceanobacillus
iheyensis) 		PF13354
(Beta-lactamase2) 		9 TYR A 118
SER A 143
ASN A 145
ASN A 183
THR A 229
LYS A 247
THR A 248
GLY A 249
GLY A 251
 EPE  A 305 (-3.3A)
EPE  A 305 (-2.5A)
None
None
EPE  A 305 ( 3.9A)
EPE  A 305 (-3.1A)
EPE  A 305 (-3.6A)
EPE  A 305 (-3.4A)
None
 0.37A 4pm5A-3lezA:
41.4		 4pm5A-3lezA:
43.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3p09 BETA-LACTAMASE

(Francisella
tularensis) 		PF13354
(Beta-lactamase2) 		7 TYR A  98
SER A 122
ASN A 162
THR A 208
LYS A 226
THR A 227
GLY A 228
 None
SO4  A 288 (-2.7A)
None
SO4  A 288 ( 4.8A)
SO4  A 288 (-3.5A)
SO4  A 288 (-3.6A)
SO4  A 288 (-3.3A)
 0.92A 4pm5A-3p09A:
39.4		 4pm5A-3p09A:
30.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q7z BETA-LACTAMASE
REGULATORY PROTEIN
BLAR1

(Staphylococcus
aureus) 		PF00905
(Transpeptidase) 		6 SER A 437
ASN A 439
LYS A 526
THR A 527
GLY A 528
GLY A 530
 BOU  A 584 (-2.8A)
BOU  A 584 (-3.5A)
BOU  A 584 (-3.3A)
BOU  A 584 (-3.6A)
BOU  A 584 (-3.7A)
BOU  A 584 ( 3.9A)
 0.64A 4pm5A-3q7zA:
18.0		 4pm5A-3q7zA:
20.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3qhy BETA-LACTAMASE

(Bacillus
anthracis) 		PF13354
(Beta-lactamase2) 		6 ASN A 132
ASN A 170
THR A 216
LYS A 234
GLY A 236
GLY A 238
 None
 0.45A 4pm5A-3qhyA:
41.8		 4pm5A-3qhyA:
43.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3qhy BETA-LACTAMASE

(Bacillus
anthracis) 		PF13354
(Beta-lactamase2) 		6 SER A 130
ASN A 132
ASN A 170
LYS A 234
GLY A 236
GLY A 238
 None
 0.64A 4pm5A-3qhyA:
41.8		 4pm5A-3qhyA:
43.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v39 D-ALANYL-D-ALANINE
CARBOXYPEPTIDASE

(Bdellovibrio
bacteriovorus) 		PF02113
(Peptidase_S13) 		5 ASN A 253
THR A 342
LYS A 357
THR A 358
GLY A 359
 TAU  A 501 (-3.1A)
None
TAU  A 501 ( 4.3A)
None
TAU  A 501 (-3.5A)
 0.31A 4pm5A-3v39A:
17.7		 4pm5A-3v39A:
20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vsk PENICILLIN-BINDING
PROTEIN 3

(Staphylococcus
aureus) 		PF00905
(Transpeptidase)
PF03717
(PBP_dimer) 		6 SER A 448
ASN A 450
THR A 603
LYS A 618
THR A 619
GLY A 620
 None
 0.76A 4pm5A-3vskA:
16.8		 4pm5A-3vskA:
19.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3w4q BETA-LACTAMASE

(Burkholderia
multivorans) 		PF13354
(Beta-lactamase2) 		8 TYR A 105
SER A 130
ASN A 132
ASN A 170
LYS A 234
THR A 235
GLY A 236
GLY A 238
 None
 0.65A 4pm5A-3w4qA:
44.0		 4pm5A-3w4qA:
57.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3zdj ENCA BETA-LACTAMASE

(synthetic
construct) 		PF13354
(Beta-lactamase2) 		8 TYR A 105
SER A 130
ASN A 132
ASN A 170
LYS A 234
THR A 235
GLY A 236
GLY A 238
 None
SO4  A1291 (-3.1A)
None
None
SO4  A1291 (-3.3A)
SO4  A1291 (-3.6A)
SO4  A1291 (-3.3A)
None
 0.68A 4pm5A-3zdjA:
38.6		 4pm5A-3zdjA:
43.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zg8 PENICILLIN-BINDING
PROTEIN 4

(Listeria
monocytogenes) 		PF00905
(Transpeptidase)
PF00912
(Transgly) 		7 SER B 449
ASN B 451
THR B 561
LYS B 575
THR B 576
GLY B 577
SER B 578
 AIX  B 800 (-2.4A)
AIX  B 800 (-2.7A)
AIX  B 800 ( 3.8A)
AIX  B 800 ( 4.0A)
AIX  B 800 (-3.4A)
AIX  B 800 ( 3.7A)
AIX  B 800 (-3.0A)
 0.72A 4pm5A-3zg8B:
17.5		 4pm5A-3zg8B:
19.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3zny CTX-M-12A ENZYME

(Klebsiella
pneumoniae) 		PF13354
(Beta-lactamase2) 		9 TYR A 105
ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
SER A 237
GLY A 238
 None
 0.42A 4pm5A-3znyA:
47.3		 4pm5A-3znyA:
82.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3zny CTX-M-12A ENZYME

(Klebsiella
pneumoniae) 		PF13354
(Beta-lactamase2) 		9 TYR A 105
SER A 130
ASN A 132
ASN A 170
LYS A 234
THR A 235
GLY A 236
SER A 237
GLY A 238
 None
 0.61A 4pm5A-3znyA:
47.3		 4pm5A-3znyA:
82.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zvt D-ALANYL-D-ALANINE
CARBOXYPEPTIDASE

(Actinomadura
sp. R39) 		PF02113
(Peptidase_S13) 		5 ASN A 300
THR A 393
LYS A 410
THR A 411
GLY A 412
 B07  A 500 ( 4.2A)
B07  A 500 ( 4.8A)
B07  A 500 (-1.6A)
B07  A 500 (-4.8A)
B07  A 500 (-3.2A)
 0.26A 4pm5A-3zvtA:
20.9		 4pm5A-3zvtA:
22.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4c6y BETA-LACTAMASE

(synthetic
construct) 		PF13354
(Beta-lactamase2) 		8 SER A 130
ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
GLY A 238
 PEG  A 307 (-2.4A)
PEG  A 307 (-3.1A)
PEG  A 307 ( 4.3A)
PEG  A 307 ( 4.3A)
PEG  A 307 ( 3.4A)
PEG  A 307 (-3.0A)
PEG  A 307 (-2.7A)
None
 0.56A 4pm5A-4c6yA:
43.4		 4pm5A-4c6yA:
58.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4c6y BETA-LACTAMASE

(synthetic
construct) 		PF13354
(Beta-lactamase2) 		7 TYR A 105
SER A 130
ASN A 132
THR A 216
LYS A 234
THR A 235
GLY A 238
 PEG  A 307 ( 3.2A)
PEG  A 307 (-2.4A)
PEG  A 307 (-3.1A)
PEG  A 307 ( 4.3A)
PEG  A 307 ( 3.4A)
PEG  A 307 (-3.0A)
None
 0.82A 4pm5A-4c6yA:
43.4		 4pm5A-4c6yA:
58.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4c75 BETA-LACTAMASE

(synthetic
construct) 		PF13354
(Beta-lactamase2) 		9 TYR A 105
SER A 130
ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
GLY A 238
 None
SO4  A 291 (-2.8A)
None
None
SO4  A 291 ( 4.1A)
SO4  A 291 (-3.4A)
SO4  A 291 (-3.8A)
NA  A 294 ( 3.2A)
None
 0.65A 4pm5A-4c75A:
42.7		 4pm5A-4c75A:
57.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4d2o PER-2 BETA-LACTAMASE

(Citrobacter
freundii) 		PF13354
(Beta-lactamase2) 		6 SER A 130
ASN A 132
THR A 216
LYS A 234
THR A 235
GLY A 236
 None
 0.49A 4pm5A-4d2oA:
32.3		 4pm5A-4d2oA:
31.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ev4 CARBAPENEM-HYDROLIZI
NG BETA-LACTAMASE
SFC-1

(Serratia
fonticola) 		PF13354
(Beta-lactamase2) 		6 ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
 MER  A 401 (-3.2A)
MER  A 401 (-2.9A)
MER  A 401 ( 3.9A)
MER  A 401 (-3.0A)
MER  A 401 (-3.5A)
MER  A 401 (-3.6A)
 0.46A 4pm5A-4ev4A:
42.1		 4pm5A-4ev4A:
48.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ev4 CARBAPENEM-HYDROLIZI
NG BETA-LACTAMASE
SFC-1

(Serratia
fonticola) 		PF13354
(Beta-lactamase2) 		6 SER A 130
ASN A 132
ASN A 170
LYS A 234
THR A 235
GLY A 236
 MER  A 401 (-2.8A)
MER  A 401 (-3.2A)
MER  A 401 (-2.9A)
MER  A 401 (-3.0A)
MER  A 401 (-3.5A)
MER  A 401 (-3.6A)
 0.75A 4pm5A-4ev4A:
42.1		 4pm5A-4ev4A:
48.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mnr PEPTIDOGLYCAN
GLYCOSYLTRANSFERASE

(Eggerthella
lenta) 		PF00905
(Transpeptidase) 		6 SER A 237
ASN A 239
THR A 383
LYS A 397
THR A 398
GLY A 399
 None
 0.62A 4pm5A-4mnrA:
17.6		 4pm5A-4mnrA:
23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oon PENICILLIN-BINDING
PROTEIN 1A

(Pseudomonas
aeruginosa) 		PF00905
(Transpeptidase)
PF00912
(Transgly)
PF17092
(PCB_OB) 		6 SER A 520
ASN A 522
THR A 680
LYS A 695
THR A 696
GLY A 697
 2U4  A 901 (-3.6A)
2U4  A 901 (-2.9A)
2U4  A 901 (-4.1A)
2U4  A 901 ( 4.3A)
2U4  A 901 (-3.7A)
2U4  A 901 (-3.7A)
 0.80A 4pm5A-4oonA:
16.9		 4pm5A-4oonA:
16.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ovd PEPTIDOGLYCAN
GLYCOSYLTRANSFERASE

(Atopobium
parvulum) 		PF00905
(Transpeptidase)
PF03717
(PBP_dimer) 		6 ASN A 363
THR A 486
LYS A 500
THR A 501
GLY A 502
GLY A 504
 None
CA  A 601 ( 4.7A)
CA  A 601 ( 4.1A)
CA  A 601 (-4.0A)
CA  A 601 ( 4.2A)
None
 0.77A 4pm5A-4ovdA:
17.7		 4pm5A-4ovdA:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ovd PEPTIDOGLYCAN
GLYCOSYLTRANSFERASE

(Atopobium
parvulum) 		PF00905
(Transpeptidase)
PF03717
(PBP_dimer) 		6 SER A 361
ASN A 363
LYS A 500
THR A 501
GLY A 502
GLY A 504
 CA  A 601 ( 3.8A)
None
CA  A 601 ( 4.1A)
CA  A 601 (-4.0A)
CA  A 601 ( 4.2A)
None
 0.92A 4pm5A-4ovdA:
17.7		 4pm5A-4ovdA:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ra7 PEPTIDOGLYCAN
GLYCOSYLTRANSFERASE

(Atopobium
parvulum) 		PF00905
(Transpeptidase) 		6 SER A 737
ASN A 739
THR A 876
LYS A 890
THR A 891
GLY A 892
 NXU  A1001 (-3.2A)
NXU  A1001 (-3.5A)
NXU  A1001 (-4.0A)
NXU  A1001 (-3.5A)
NXU  A1001 (-3.3A)
NXU  A1001 (-3.4A)
 0.62A 4pm5A-4ra7A:
16.9		 4pm5A-4ra7A:
22.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4yfm BETA-LACTAMASE

(Mycobacteroides
abscessus) 		PF13354
(Beta-lactamase2) 		8 SER A 131
ASN A 133
ASN A 171
THR A 215
LYS A 233
THR A 234
GLY A 235
GLY A 237
 ACT  A 301 (-2.9A)
None
None
ACT  A 301 (-3.7A)
ACT  A 301 (-3.4A)
ACT  A 301 (-3.5A)
ACT  A 301 (-3.3A)
None
 0.61A 4pm5A-4yfmA:
41.8		 4pm5A-4yfmA:
44.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ztk CELL DIVISION
PROTEIN
FTSI/PENICILLIN
BINDING PROTEIN 2

(Legionella
pneumophila) 		PF00905
(Transpeptidase) 		6 SER A 454
ASN A 456
THR A 554
LYS A 568
THR A 569
GLY A 570
 NHE  A 901 (-2.9A)
None
NHE  A 901 ( 4.2A)
NHE  A 901 (-3.0A)
NHE  A 901 (-3.6A)
NHE  A 901 (-3.6A)
 0.66A 4pm5A-4ztkA:
16.8		 4pm5A-4ztkA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5aqa OFF7_DB04V3

(synthetic
construct) 		PF00023
(Ank)
PF12796
(Ank_2)
PF13354
(Beta-lactamase2) 		6 SER A 260
ASN A 262
ASN A 300
LYS A 364
GLY A 366
GLY A 368
 None
 0.74A 4pm5A-5aqaA:
37.5		 4pm5A-5aqaA:
26.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cer BD0816

(Bdellovibrio
bacteriovorus) 		PF02113
(Peptidase_S13) 		5 ASN A 241
THR A 330
LYS A 345
THR A 346
GLY A 347
 None
 0.29A 4pm5A-5cerA:
18.3		 4pm5A-5cerA:
20.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ctm BETA-LACTAMASE

(Bacillus
pumilus) 		PF00905
(Transpeptidase) 		6 SER A 149
LYS A 239
THR A 240
GLY A 241
SER A 242
GLY A 243
 FLC  A 301 (-2.5A)
FLC  A 301 (-3.0A)
FLC  A 301 (-3.8A)
FLC  A 301 (-3.2A)
FLC  A 301 (-2.8A)
None
 0.59A 4pm5A-5ctmA:
18.7		 4pm5A-5ctmA:
22.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5e2e BETA-LACTAMASE

(Yersinia
enterocolitica) 		PF13354
(Beta-lactamase2) 		9 TYR A  82
ASN A 109
ASN A 147
THR A 193
LYS A 211
THR A 212
GLY A 213
SER A 214
GLY A 215
 None
 0.52A 4pm5A-5e2eA:
44.3		 4pm5A-5e2eA:
58.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5e2e BETA-LACTAMASE

(Yersinia
enterocolitica) 		PF13354
(Beta-lactamase2) 		9 TYR A  82
SER A 107
ASN A 109
ASN A 147
LYS A 211
THR A 212
GLY A 213
SER A 214
GLY A 215
 None
 0.70A 4pm5A-5e2eA:
44.3		 4pm5A-5e2eA:
58.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e31 PENICILLIN BINDING
PROTEIN 2 PRIME

(Enterococcus
faecium) 		PF00905
(Transpeptidase)
PF03717
(PBP_dimer)
PF05223
(MecA_N) 		6 SER A 480
ASN A 482
THR A 603
LYS A 617
THR A 618
GLY A 619
 None
 0.67A 4pm5A-5e31A:
17.0		 4pm5A-5e31A:
17.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5e43 BETA-LACTAMASE

(Streptosporangium
roseum) 		PF13354
(Beta-lactamase2) 		7 SER A 131
ASN A 133
ASN A 171
THR A 217
LYS A 235
THR A 236
GLY A 237
 ACT  A 311 (-3.0A)
None
None
ACT  A 311 ( 3.9A)
ACT  A 311 (-3.3A)
ACT  A 311 (-3.7A)
ACT  A 311 (-3.2A)
 0.59A 4pm5A-5e43A:
42.7		 4pm5A-5e43A:
41.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5eoe BETA-LACTAMASE

(Pseudomonas
aeruginosa) 		PF13354
(Beta-lactamase2) 		6 THR A 209
LYS A 227
THR A 228
GLY A 229
SER A 230
GLY A 235
 CIT  A 303 (-3.2A)
CIT  A 303 (-3.5A)
CIT  A 303 (-3.6A)
CIT  A 303 (-3.5A)
CIT  A 303 (-2.5A)
None
 1.23A 4pm5A-5eoeA:
40.7		 4pm5A-5eoeA:
41.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5eoe BETA-LACTAMASE

(Pseudomonas
aeruginosa) 		PF13354
(Beta-lactamase2) 		8 TYR A  97
ASN A 125
ASN A 163
THR A 209
LYS A 227
THR A 228
GLY A 229
SER A 230
 CIT  A 303 (-4.1A)
CIT  A 303 (-3.2A)
None
CIT  A 303 (-3.2A)
CIT  A 303 (-3.5A)
CIT  A 303 (-3.6A)
CIT  A 303 (-3.5A)
CIT  A 303 (-2.5A)
 0.52A 4pm5A-5eoeA:
40.7		 4pm5A-5eoeA:
41.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5eoe BETA-LACTAMASE

(Pseudomonas
aeruginosa) 		PF13354
(Beta-lactamase2) 		8 TYR A  97
SER A 123
ASN A 125
ASN A 163
LYS A 227
THR A 228
GLY A 229
SER A 230
 CIT  A 303 (-4.1A)
CIT  A 303 (-2.5A)
CIT  A 303 (-3.2A)
None
CIT  A 303 (-3.5A)
CIT  A 303 (-3.6A)
CIT  A 303 (-3.5A)
CIT  A 303 (-2.5A)
 0.71A 4pm5A-5eoeA:
40.7		 4pm5A-5eoeA:
41.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5f83 BETA-LACTAMASE

(Pseudomonas
aeruginosa) 		PF13354
(Beta-lactamase2) 		5 ASN A 127
THR A 211
LYS A 229
THR A 230
GLY A 231
 IM2  A 301 (-3.2A)
IM2  A 301 (-4.1A)
IM2  A 301 (-3.3A)
IM2  A 301 (-3.6A)
IM2  A 301 (-3.3A)
 0.21A 4pm5A-5f83A:
39.4		 4pm5A-5f83A:
37.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5gl9 BETA-LACTAMASE

(Burkholderia
thailandensis) 		PF13354
(Beta-lactamase2) 		8 SER A 130
ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
GLY A 238
 None
 0.55A 4pm5A-5gl9A:
45.0		 4pm5A-5gl9A:
57.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5gl9 BETA-LACTAMASE

(Burkholderia
thailandensis) 		PF13354
(Beta-lactamase2) 		7 TYR A 105
SER A 130
ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
 None
 0.86A 4pm5A-5gl9A:
45.0		 4pm5A-5gl9A:
57.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hlb PENICILLIN-BINDING
PROTEIN 1B

(Escherichia
coli) 		PF00905
(Transpeptidase)
PF00912
(Transgly)
PF14814
(UB2H) 		6 SER A 572
ASN A 574
THR A 682
LYS A 698
THR A 699
GLY A 700
 AZR  A 902 ( 3.7A)
AZR  A 902 (-3.4A)
AZR  A 902 (-3.4A)
AZR  A 902 ( 4.5A)
AZR  A 902 (-3.5A)
AZR  A 902 (-3.3A)
 0.77A 4pm5A-5hlbA:
18.5		 4pm5A-5hlbA:
18.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hx9 BETA-LACTAMASE

(Burkholderia
vietnamiensis) 		PF13354
(Beta-lactamase2) 		5 GLY A  70
ASN A 170
LYS A 234
GLY A 236
GLY A 238
 EDO  A 303 (-3.6A)
None
EDO  A 303 (-2.6A)
None
None
 0.22A 4pm5A-5hx9A:
41.4		 4pm5A-5hx9A:
46.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ihv BETA-LACTAMASE

(Burkholderia
ambifaria) 		PF13354
(Beta-lactamase2) 		5 GLY A  47
ASN A 147
LYS A 211
GLY A 213
GLY A 215
 EDO  A 302 (-3.6A)
None
EDO  A 302 (-2.8A)
None
None
 0.22A 4pm5A-5ihvA:
41.9		 4pm5A-5ihvA:
49.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ll7 BETA-LACTAMASE

(Escherichia
coli) 		no annotation 7 SER A 130
ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
 6YV  A 301 (-2.6A)
6YV  A 301 (-3.7A)
6YV  A 301 (-2.9A)
6YV  A 301 ( 4.2A)
6YV  A 301 (-3.6A)
6YV  A 301 (-3.6A)
6YV  A 301 ( 4.0A)
 0.65A 4pm5A-5ll7A:
43.1		 4pm5A-5ll7A:
16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ll7 BETA-LACTAMASE

(Escherichia
coli) 		no annotation 6 SER A 130
THR A 216
LYS A 234
THR A 235
GLY A 236
GLY A 239
 6YV  A 301 (-2.6A)
6YV  A 301 ( 4.2A)
6YV  A 301 (-3.6A)
6YV  A 301 (-3.6A)
6YV  A 301 ( 4.0A)
None
 0.88A 4pm5A-5ll7A:
43.1		 4pm5A-5ll7A:
16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tfq BETA-LACTAMASE

(Bacteroides
cellulosilyticus) 		PF13354
(Beta-lactamase2) 		8 TYR A  85
SER A 112
ASN A 114
THR A 197
LYS A 215
THR A 216
GLY A 217
SER A 218
 None
PO4  A 301 (-2.6A)
None
PO4  A 301 ( 3.8A)
PO4  A 301 (-3.2A)
PO4  A 301 ( 3.6A)
PO4  A 301 (-3.3A)
PO4  A 301 (-2.7A)
 0.61A 4pm5A-5tfqA:
33.0		 4pm5A-5tfqA:
26.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u2g PENICILLIN-BINDING
PROTEIN 1A

(Haemophilus
influenzae) 		PF00905
(Transpeptidase)
PF00912
(Transgly)
PF17092
(PCB_OB) 		6 SER A 510
ASN A 512
THR A 712
LYS A 728
THR A 729
GLY A 730
 None
None
None
None
CL  A 910 ( 4.2A)
None
 0.79A 4pm5A-5u2gA:
17.8		 4pm5A-5u2gA:
15.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5vpq BETA-LACTAMASE

(Paraburkholderia
phymatum) 		PF13354
(Beta-lactamase2) 		7 ASN A 121
ASN A 159
THR A 206
THR A 226
GLY A 227
SER A 228
GLY A 229
 None
None
None
None
None
EDO  A 304 ( 4.8A)
EDO  A 304 (-3.4A)
 0.71A 4pm5A-5vpqA:
41.4		 4pm5A-5vpqA:
48.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5vpq BETA-LACTAMASE

(Paraburkholderia
phymatum) 		PF13354
(Beta-lactamase2) 		6 SER A 119
THR A 206
THR A 226
GLY A 227
SER A 228
GLY A 229
 None
None
None
None
EDO  A 304 ( 4.8A)
EDO  A 304 (-3.4A)
 0.75A 4pm5A-5vpqA:
41.4		 4pm5A-5vpqA:
48.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x5g BETA-LACTAMASE

(Serratia
marcescens) 		PF13354
(Beta-lactamase2) 		7 SER A 120
ASN A 122
THR A 206
LYS A 224
THR A 225
GLY A 226
SER A 227
 OP0  A 305 (-2.7A)
OP0  A 305 (-3.1A)
OP0  A 305 (-3.6A)
OP0  A 305 (-3.4A)
OP0  A 305 (-3.7A)
OP0  A 305 (-3.2A)
OP0  A 305 (-2.4A)
 0.73A 4pm5A-5x5gA:
34.5		 4pm5A-5x5gA:
26.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5zqe -

(-) 		no annotation 5 ASN A 120
THR A 208
LYS A 222
THR A 223
GLY A 224
 CES  A 301 (-3.3A)
CES  A 301 (-4.3A)
None
CES  A 301 (-3.6A)
CES  A 301 (-3.2A)
 0.27A 4pm5A-5zqeA:
22.1		 4pm5A-5zqeA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6azi D-ALANYL-D-ALANINE
ENDOPEPTIDASE

(Enterobacter
cloacae) 		PF00768
(Peptidase_S11) 		5 ASN A 127
THR A 217
LYS A 232
THR A 233
GLY A 234
 SEE  A  68 ( 3.6A)
None
SEE  A  68 ( 3.5A)
None
SEE  A  68 ( 3.9A)
 0.32A 4pm5A-6aziA:
21.4		 4pm5A-6aziA:
27.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6bu3 BETA-LACTAMASE

(Escherichia
coli) 		no annotation 11 ASN A 104
TYR A 105
SER A 130
ASN A 132
ASN A 170
THR A 216
LYS A 234
THR A 235
GLY A 236
SER A 237
GLY A 238
 3GK  A 301 ( 3.2A)
3GK  A 302 ( 3.5A)
3GK  A 301 (-2.7A)
3GK  A 301 (-3.5A)
3GK  A 301 (-3.9A)
3GK  A 302 ( 4.3A)
3GK  A 301 ( 4.1A)
3GK  A 301 (-3.7A)
3GK  A 301 (-3.4A)
3GK  A 301 ( 2.7A)
3GK  A 301 (-3.6A)
 0.46A 4pm5A-6bu3A:
48.6		 4pm5A-6bu3A:
97.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dci DIENOYL-COA
ISOMERASE

(Rattus
norvegicus) 		PF00378
(ECH_1) 		3 CYH A 186
PRO A 247
ASP A 234
 None
 0.97A 4pm5A-1dciA:
0.0		 4pm5A-1dciA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dqw OROTIDINE
5'-PHOSPHATE
DECARBOXYLASE

(Saccharomyces
cerevisiae) 		PF00215
(OMPdecase) 		3 CYH A  33
PRO A 202
ASP A  91
 None
 0.98A 4pm5A-1dqwA:
undetectable		 4pm5A-1dqwA:
22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1evj GLUCOSE-FRUCTOSE
OXIDOREDUCTASE

(Zymomonas
mobilis) 		PF01408
(GFO_IDH_MocA)
PF02894
(GFO_IDH_MocA_C) 		3 CYH A 138
PRO A 345
ASP A 352
 None
 0.97A 4pm5A-1evjA:
undetectable		 4pm5A-1evjA:
24.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fez PHOSPHONOACETALDEHYD
E HYDROLASE

(Bacillus cereus) 		PF13419
(HAD_2) 		3 CYH A 166
PRO A 153
ASP A 190
 None
 1.02A 4pm5A-1fezA:
undetectable		 4pm5A-1fezA:
23.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fvf SEC1

(Doryteuthis
pealeii) 		PF00995
(Sec1) 		3 CYH A 169
PRO A 164
ASP A 148
 None
 0.86A 4pm5A-1fvfA:
0.0		 4pm5A-1fvfA:
18.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h6d PRECURSOR FORM OF
GLUCOSE-FRUCTOSE
OXIDOREDUCTASE

(Zymomonas
mobilis) 		PF01408
(GFO_IDH_MocA)
PF02894
(GFO_IDH_MocA_C) 		3 CYH A 190
PRO A 397
ASP A 404
 None
 0.98A 4pm5A-1h6dA:
0.0		 4pm5A-1h6dA:
23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hg3 TRIOSEPHOSPHATE
ISOMERASE

(Pyrococcus
woesei) 		PF00121
(TIM)
PF05690
(ThiG) 		3 CYH A 181
PRO A 160
ASP A 190
 None
 0.99A 4pm5A-1hg3A:
undetectable		 4pm5A-1hg3A:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1n21 (+)-BORNYL
DIPHOSPHATE SYNTHASE

(Salvia
officinalis) 		PF01397
(Terpene_synth)
PF03936
(Terpene_synth_C) 		3 CYH A 388
PRO A 307
ASP A 352
 None
 0.93A 4pm5A-1n21A:
0.0		 4pm5A-1n21A:
18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pv5 HYPOTHETICAL PROTEIN
YWQG

(Bacillus
subtilis) 		PF09234
(DUF1963) 		3 CYH A 134
PRO A 137
ASP A  91
 None
 0.98A 4pm5A-1pv5A:
undetectable		 4pm5A-1pv5A:
21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qr0 4'-PHOSPHOPANTETHEIN
YL TRANSFERASE SFP

(Bacillus
subtilis) 		PF01648
(ACPS) 		3 CYH A  32
PRO A  26
ASP A  48
 None
 0.95A 4pm5A-1qr0A:
undetectable		 4pm5A-1qr0A:
18.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v72 ALDOLASE

(Pseudomonas
putida) 		PF01212
(Beta_elim_lyase) 		3 CYH A  75
PRO A 102
ASP A 179
 None
None
PLP  A 513 (-2.8A)
 0.90A 4pm5A-1v72A:
undetectable		 4pm5A-1v72A:
22.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1z06 RAS-RELATED PROTEIN
RAB-33B

(Mus musculus) 		PF00071
(Ras) 		3 CYH A  54
PRO A  59
ASP A  88
 None
None
MG  A 203 ( 3.8A)
 0.88A 4pm5A-1z06A:
undetectable		 4pm5A-1z06A:
18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fcr FLAVODOXIN

(Chondrus
crispus) 		PF00258
(Flavodoxin_1) 		3 CYH A 103
PRO A  99
ASP A 148
 FMN  A 174 (-4.3A)
None
None
 0.78A 4pm5A-2fcrA:
undetectable		 4pm5A-2fcrA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ffw MIDLINE-1

(Homo sapiens) 		no annotation 3 CYH A 122
PRO A 126
ASP A 129
 ZN  A 200 (-2.3A)
None
None
 1.00A 4pm5A-2ffwA:
undetectable		 4pm5A-2ffwA:
17.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g29 NITRATE TRANSPORT
PROTEIN NRTA

(Synechocystis
sp.) 		PF13379
(NMT1_2) 		3 CYH A 309
PRO A 321
ASP A 327
 None
 0.87A 4pm5A-2g29A:
undetectable		 4pm5A-2g29A:
20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g4o 3-ISOPROPYLMALATE
DEHYDROGENASE

(Mycobacterium
tuberculosis) 		PF00180
(Iso_dh) 		3 CYH A 245
PRO A 103
ASP A 116
 None
 0.66A 4pm5A-2g4oA:
undetectable		 4pm5A-2g4oA:
24.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gqe NUCLEAR PORE COMPLEX
PROTEIN NUP153

(Homo sapiens) 		PF00641
(zf-RanBP) 		3 CYH A  23
PRO A  18
ASP A   8
 ZN  A  32 (-2.4A)
None
None
 0.65A 4pm5A-2gqeA:
undetectable		 4pm5A-2gqeA:
9.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hne L-FUCONATE
DEHYDRATASE

(Xanthomonas
campestris) 		PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C) 		3 CYH A 358
PRO A 394
ASP A 385
 None
 0.43A 4pm5A-2hneA:
undetectable		 4pm5A-2hneA:
25.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ox1 3-DEHYDROQUINATE
DEHYDRATASE

(Archaeoglobus
fulgidus) 		PF01487
(DHquinase_I) 		3 CYH A 172
PRO A 177
ASP A 187
 None
 0.84A 4pm5A-2ox1A:
undetectable		 4pm5A-2ox1A:
22.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oy0 METHYLTRANSFERASE

(West Nile virus) 		PF01728
(FtsJ) 		3 CYH A 140
PRO A  73
ASP A  79
 None
 1.02A 4pm5A-2oy0A:
undetectable		 4pm5A-2oy0A:
20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qdd MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME

(Roseovarius
nubinhibens) 		PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C) 		3 CYH A  51
PRO A  63
ASP A  12
 None
 0.99A 4pm5A-2qddA:
undetectable		 4pm5A-2qddA:
24.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2v7y CHAPERONE PROTEIN
DNAK

(Geobacillus
kaustophilus) 		PF00012
(HSP70) 		3 CYH A  15
PRO A  37
ASP A 337
 None
None
ADP  A1505 ( 4.6A)
 0.93A 4pm5A-2v7yA:
undetectable		 4pm5A-2v7yA:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vr2 DIHYDROPYRIMIDINASE

(Homo sapiens) 		PF01979
(Amidohydro_1) 		3 CYH A 433
PRO A 437
ASP A 354
 None
 0.93A 4pm5A-2vr2A:
undetectable		 4pm5A-2vr2A:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vre DELTA(3,5)-DELTA(2,4
)-DIENOYL-COA
ISOMERASE

(Homo sapiens) 		PF00378
(ECH_1) 		3 CYH A 161
PRO A 222
ASP A 209
 None
 0.85A 4pm5A-2vreA:
undetectable		 4pm5A-2vreA:
20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w9z G1/S-SPECIFIC
CYCLIN-D1

(Homo sapiens) 		PF00134
(Cyclin_N)
PF02984
(Cyclin_C) 		3 CYH A 106
PRO A  79
ASP A  86
 None
 0.82A 4pm5A-2w9zA:
undetectable		 4pm5A-2w9zA:
20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2whx SERINE
PROTEASE/NTPASE/HELI
CASE NS3

(Dengue virus) 		PF00949
(Peptidase_S7)
PF07652
(Flavi_DEAD) 		3 CYH A 428
PRO A 478
ASP A 482
 None
 0.94A 4pm5A-2whxA:
undetectable		 4pm5A-2whxA:
17.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2wyx BETA-LACTAMSE TOHO-1

(Escherichia
coli) 		PF13354
(Beta-lactamase2) 		3 CYH A  69
PRO A 167
ASP A 240
 None
 0.55A 4pm5A-2wyxA:
46.0		 4pm5A-2wyxA:
83.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xgt ASPARAGINYL-TRNA
SYNTHETASE,
CYTOPLASMIC

(Brugia malayi) 		PF00152
(tRNA-synt_2)
PF01336
(tRNA_anti-codon) 		3 CYH A 341
PRO A 512
ASP A 348
 None
 0.99A 4pm5A-2xgtA:
undetectable		 4pm5A-2xgtA:
21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xu2 UPF0271 PROTEIN
PA4511

(Pseudomonas
aeruginosa) 		PF03746
(LamB_YcsF) 		3 CYH A  13
PRO A  32
ASP A  26
 None
 0.92A 4pm5A-2xu2A:
undetectable		 4pm5A-2xu2A:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z6v PUTATIVE
UNCHARACTERIZED
PROTEIN

(Mycobacterium
avium) 		PF13469
(Sulfotransfer_3) 		3 CYH A 120
PRO A 168
ASP A 171
 None
 0.76A 4pm5A-2z6vA:
undetectable		 4pm5A-2z6vA:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3anv D-SERINE DEHYDRATASE

(Gallus gallus) 		PF01168
(Ala_racemase_N)
PF14031
(D-ser_dehydrat) 		3 CYH A 256
PRO A 223
ASP A 247
 None
 1.02A 4pm5A-3anvA:
undetectable		 4pm5A-3anvA:
21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3au7 PUTATIVE
UNCHARACTERIZED
PROTEIN

(Archaeoglobus
fulgidus) 		PF01336
(tRNA_anti-codon)
PF08489
(DUF1743) 		3 CYH A 204
PRO A 398
ASP A 184
 None
 0.92A 4pm5A-3au7A:
undetectable		 4pm5A-3au7A:
22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b9g IAG-NUCLEOSIDE
HYDROLASE

(Trypanosoma
vivax) 		PF01156
(IU_nuc_hydro) 		3 CYH A  55
PRO A  99
ASP A 106
 None
 1.01A 4pm5A-3b9gA:
undetectable		 4pm5A-3b9gA:
24.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bd1 CRO PROTEIN

(Xylella
fastidiosa) 		PF15943
(YdaS_antitoxin) 		3 CYH A  55
PRO A  38
ASP A  44
 None
GOL  A 156 (-4.8A)
None
 1.02A 4pm5A-3bd1A:
undetectable		 4pm5A-3bd1A:
16.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3byd BETA-LACTAMASE OXY-1

(Klebsiella
oxytoca) 		PF13354
(Beta-lactamase2) 		3 CYH A  72
PRO A 170
ASP A 242
 None
 0.48A 4pm5A-3bydA:
47.3		 4pm5A-3bydA:
74.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ch5 FRAGMENT OF NUCLEAR
PORE COMPLEX PROTEIN
NUP153

(Rattus
norvegicus) 		PF00641
(zf-RanBP) 		3 CYH B 741
PRO B 736
ASP B 726
 ZN  B 800 (-2.4A)
None
None
 1.02A 4pm5A-3ch5B:
undetectable		 4pm5A-3ch5B:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cr8 SULFATE
ADENYLYLTRANSFERASE,
ADENYLYLSULFATE
KINASE

(Thiobacillus
denitrificans) 		PF01583
(APS_kinase)
PF01747
(ATP-sulfurylase)
PF14306
(PUA_2) 		3 CYH A  43
PRO A 140
ASP A 203
 None
 1.01A 4pm5A-3cr8A:
undetectable		 4pm5A-3cr8A:
21.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dwz BETA-LACTAMASE

(Mycobacterium
tuberculosis) 		PF13354
(Beta-lactamase2) 		3 CYH A  83
PRO A 183
ASP A 255
 DWZ  A 400 (-4.9A)
None
None
 0.82A 4pm5A-3dwzA:
41.1		 4pm5A-3dwzA:
45.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dzu RETINOIC ACID
RECEPTOR RXR-ALPHA

(Homo sapiens) 		PF00104
(Hormone_recep)
PF00105
(zf-C4) 		3 CYH A 269
PRO A 264
ASP A 444
 None
 1.01A 4pm5A-3dzuA:
undetectable		 4pm5A-3dzuA:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3edv SPECTRIN BETA CHAIN,
BRAIN 1

(Homo sapiens) 		PF00435
(Spectrin) 		3 CYH A1900
PRO A1829
ASP A1852
 None
 1.01A 4pm5A-3edvA:
undetectable		 4pm5A-3edvA:
21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g33 CCND3 PROTEIN

(Homo sapiens) 		PF00134
(Cyclin_N)
PF02984
(Cyclin_C) 		3 CYH B 106
PRO B  79
ASP B  86
 None
 0.85A 4pm5A-3g33B:
undetectable		 4pm5A-3g33B:
23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gd9 LAMINARIPENTAOSE-PRO
DUCING
BETA-1,3-GULUASE
(LPHASE)

(Streptomyces
matensis) 		PF16483
(Glyco_hydro_64) 		3 CYH A 306
PRO A 230
ASP A 376
 BGC  A   4 (-4.8A)
None
None
 1.00A 4pm5A-3gd9A:
undetectable		 4pm5A-3gd9A:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gd9 LAMINARIPENTAOSE-PRO
DUCING
BETA-1,3-GULUASE
(LPHASE)

(Streptomyces
matensis) 		PF16483
(Glyco_hydro_64) 		3 CYH A 326
PRO A 320
ASP A 311
 None
 0.97A 4pm5A-3gd9A:
undetectable		 4pm5A-3gd9A:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gg0 KLEBSIELLA
PNEUMONIAE BLRP1

(Klebsiella
pneumoniae) 		PF00563
(EAL)
PF04940
(BLUF) 		3 CYH A 169
PRO A 199
ASP A 215
 None
C2E  A 501 (-4.3A)
C2E  A 501 (-3.2A)
 0.99A 4pm5A-3gg0A:
undetectable		 4pm5A-3gg0A:
20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h3l PUTATIVE SUGAR
HYDROLASE

(Parabacteroides
distasonis) 		PF06439
(DUF1080) 		3 CYH A 234
PRO A 231
ASP A 169
 None
 0.88A 4pm5A-3h3lA:
undetectable		 4pm5A-3h3lA:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iwk AMINOALDEHYDE
DEHYDROGENASE

(Pisum sativum) 		PF00171
(Aldedh) 		3 CYH A 100
PRO A 160
ASP A 110
 None
NAD  A 505 (-4.4A)
None
 0.98A 4pm5A-3iwkA:
undetectable		 4pm5A-3iwkA:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j7a 40S RIBOSOMAL
PROTEIN ES1

(Plasmodium
falciparum) 		PF01015
(Ribosomal_S3Ae) 		3 CYH B  96
PRO B  35
ASP B  89
 None
 0.83A 4pm5A-3j7aB:
undetectable		 4pm5A-3j7aB:
23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kie CAPSID PROTEIN VP1

(Adeno-associated
dependoparvovirus
A) 		PF00740
(Parvo_coat) 		3 CYH A 289
PRO A 617
ASP A 283
 None
 0.98A 4pm5A-3kieA:
undetectable		 4pm5A-3kieA:
17.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lj8 TYROSINE-PROTEIN
PHOSPHATASE

(Homo sapiens) 		PF00782
(DSPc) 		3 CYH A 290
PRO A 256
ASP A 259
 None
 0.98A 4pm5A-3lj8A:
undetectable		 4pm5A-3lj8A:
19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3llx PREDICTED AMINO ACID
ALDOLASE OR RACEMASE

(Idiomarina
loihiensis) 		PF01168
(Ala_racemase_N)
PF14031
(D-ser_dehydrat) 		3 CYH A 250
PRO A 218
ASP A 241
 None
 0.97A 4pm5A-3llxA:
undetectable		 4pm5A-3llxA:
22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lud PROTEIN ARGONAUTE-2

(Homo sapiens) 		PF02171
(Piwi)
PF16487
(ArgoMid) 		3 CYH A 564
PRO A 557
ASP A 480
 None
 0.90A 4pm5A-3ludA:
undetectable		 4pm5A-3ludA:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nfz ASPARTOACYLASE-2

(Mus musculus) 		PF04952
(AstE_AspA) 		3 CYH A  26
PRO A 182
ASP A 189
 None
 0.87A 4pm5A-3nfzA:
undetectable		 4pm5A-3nfzA:
23.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3p3l CYTOCHROME P450

(Streptomyces
thioluteus) 		PF00067
(p450) 		3 CYH A 153
PRO A 148
ASP A 164
 None
 0.98A 4pm5A-3p3lA:
undetectable		 4pm5A-3p3lA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qml 78 KDA
GLUCOSE-REGULATED
PROTEIN HOMOLOG

(Saccharomyces
cerevisiae) 		PF00012
(HSP70) 		3 CYH A  63
PRO A  85
ASP A 411
 None
 1.02A 4pm5A-3qmlA:
undetectable		 4pm5A-3qmlA:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qyn TUMOR PROTEIN 63

(Homo sapiens) 		PF00870
(P53) 		3 CYH A 306
PRO A 281
ASP A 316
 None
 0.93A 4pm5A-3qynA:
undetectable		 4pm5A-3qynA:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ru6 OROTIDINE
5'-PHOSPHATE
DECARBOXYLASE

(Campylobacter
jejuni) 		PF00215
(OMPdecase) 		3 CYH A   4
PRO A 174
ASP A  58
 None
 0.97A 4pm5A-3ru6A:
undetectable		 4pm5A-3ru6A:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s6b METHIONINE
AMINOPEPTIDASE

(Plasmodium
falciparum) 		PF00557
(Peptidase_M24) 		3 CYH A 166
PRO A 163
ASP A 137
 None
 0.98A 4pm5A-3s6bA:
undetectable		 4pm5A-3s6bA:
20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3shm CAPSID PROTEIN VP1

(Adeno-associated
dependoparvovirus
A) 		PF00740
(Parvo_coat) 		3 CYH A 290
PRO A 617
ASP A 284
 None
 0.97A 4pm5A-3shmA:
undetectable		 4pm5A-3shmA:
17.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sma FRBF

(Streptomyces
rubellomurinus) 		PF02522
(Antibiotic_NAT) 		3 CYH A 241
PRO A 246
ASP A 268
 None
 0.95A 4pm5A-3smaA:
undetectable		 4pm5A-3smaA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sqg METHYL-COENZYME M
REDUCTASE, BETA
SUBUNIT

(uncultured
archaeon) 		PF02241
(MCR_beta)
PF02783
(MCR_beta_N) 		3 CYH B 331
PRO B 341
ASP B 344
 None
 0.80A 4pm5A-3sqgB:
undetectable		 4pm5A-3sqgB:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3trd ALPHA/BETA HYDROLASE

(Coxiella
burnetii) 		PF00561
(Abhydrolase_1) 		3 CYH A  34
PRO A  38
ASP A  87
 None
 0.90A 4pm5A-3trdA:
undetectable		 4pm5A-3trdA:
23.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tre ELONGATION FACTOR P

(Coxiella
burnetii) 		PF01132
(EFP)
PF08207
(EFP_N)
PF09285
(Elong-fact-P_C) 		3 CYH A  22
PRO A  63
ASP A  18
 None
 0.96A 4pm5A-3treA:
undetectable		 4pm5A-3treA:
21.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uai H/ACA
RIBONUCLEOPROTEIN
COMPLEX SUBUNIT 1

(Saccharomyces
cerevisiae) 		PF04410
(Gar1) 		3 CYH C  53
PRO C  46
ASP C 107
 None
 0.98A 4pm5A-3uaiC:
undetectable		 4pm5A-3uaiC:
18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vzx HEPTAPRENYLGLYCERYL
PHOSPHATE SYNTHASE

(Bacillus
subtilis) 		PF01884
(PcrB) 		3 CYH A 119
PRO A 123
ASP A 141
 None
 0.90A 4pm5A-3vzxA:
undetectable		 4pm5A-3vzxA:
21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a0l CULLIN-4B

(Homo sapiens) 		PF00888
(Cullin)
PF10557
(Cullin_Nedd8) 		3 CYH E 787
PRO E 797
ASP E 801
 None
 0.86A 4pm5A-4a0lE:
undetectable		 4pm5A-4a0lE:
15.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b90 DIHYDROPYRIMIDINASE-
RELATED PROTEIN 5

(Homo sapiens) 		PF01979
(Amidohydro_1) 		3 CYH A 432
PRO A 436
ASP A 353
 None
 0.98A 4pm5A-4b90A:
undetectable		 4pm5A-4b90A:
19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b92 DIHYDROPYRIMIDINASE-
RELATED PROTEIN 5

(Homo sapiens) 		PF01979
(Amidohydro_1) 		3 CYH A 432
PRO A 436
ASP A 353
 None
 0.93A 4pm5A-4b92A:
undetectable		 4pm5A-4b92A:
22.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cv5 PROTEIN CAF40

(Saccharomyces
cerevisiae) 		PF04078
(Rcd1) 		3 CYH B 185
PRO B 190
ASP B 137
 None
 0.80A 4pm5A-4cv5B:
undetectable		 4pm5A-4cv5B:
22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e51 HISTIDINE--TRNA
LIGASE

(Burkholderia
thailandensis) 		PF03129
(HGTP_anticodon)
PF13393
(tRNA-synt_His) 		3 CYH A 309
PRO A 109
ASP A 146
 None
 0.97A 4pm5A-4e51A:
undetectable		 4pm5A-4e51A:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ip4 MANDELATE
RACEMASE/MUCONATE
LACTONIZING
ENZYME-LIKE PROTEIN

(Ruegeria sp.
TM1040) 		PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C) 		3 CYH A 356
PRO A 392
ASP A 383
 None
 0.42A 4pm5A-4ip4A:
undetectable		 4pm5A-4ip4A:
20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k7d E3 UBIQUITIN-PROTEIN
LIGASE PARKIN

(Rattus
norvegicus) 		PF01485
(IBR) 		3 CYH A 238
PRO A 247
ASP A 262
 ZN  A 503 (-2.3A)
None
None
 0.99A 4pm5A-4k7dA:
undetectable		 4pm5A-4k7dA:
20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kma GM14141P

(Drosophila
melanogaster) 		PF05076
(SUFU)
PF12470
(SUFU_C) 		3 CYH A 143
PRO A 312
ASP A 154
 None
 0.73A 4pm5A-4kmaA:
undetectable		 4pm5A-4kmaA:
18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4krf PROTEIN ARGONAUTE-1

(Homo sapiens) 		PF02170
(PAZ)
PF02171
(Piwi)
PF08699
(ArgoL1)
PF16486
(ArgoN)
PF16487
(ArgoMid)
PF16488
(ArgoL2) 		3 CYH A 562
PRO A 555
ASP A 478
 None
 1.02A 4pm5A-4krfA:
undetectable		 4pm5A-4krfA:
16.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4n3z RAB5 GDP/GTP
EXCHANGE FACTOR

(Homo sapiens) 		PF02204
(VPS9) 		3 CYH A 290
PRO A 284
ASP A 279
 None
 0.88A 4pm5A-4n3zA:
undetectable		 4pm5A-4n3zA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4okd ISOAMYLASE

(Chlamydomonas
reinhardtii) 		PF00128
(Alpha-amylase)
PF02922
(CBM_48) 		3 CYH A 684
PRO A 742
ASP A 754
 None
 0.93A 4pm5A-4okdA:
undetectable		 4pm5A-4okdA:
15.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oqj PKS

(Streptomyces
albus) 		PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
PF16197
(KAsynt_C_assoc) 		3 CYH A 574
PRO A 581
ASP A 592
 None
 0.80A 4pm5A-4oqjA:
undetectable		 4pm5A-4oqjA:
16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rdj CAPSID

(Norwalk virus) 		PF00915
(Calici_coat)
PF08435
(Calici_coat_C) 		3 CYH A 287
PRO A 322
ASP A 310
 None
 0.91A 4pm5A-4rdjA:
undetectable		 4pm5A-4rdjA:
21.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5e2e BETA-LACTAMASE

(Yersinia
enterocolitica) 		PF13354
(Beta-lactamase2) 		3 CYH A  46
PRO A 144
ASP A 216
 None
 0.30A 4pm5A-5e2eA:
44.3		 4pm5A-5e2eA:
58.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e84 78 KDA
GLUCOSE-REGULATED
PROTEIN

(Homo sapiens) 		PF00012
(HSP70) 		3 CYH A  41
PRO A  63
ASP A 391
 None
 0.93A 4pm5A-5e84A:
undetectable		 4pm5A-5e84A:
18.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f7o METHYLTHIOADENOSINE
PHOSPHORYLASE

(Schistosoma
mansoni) 		PF01048
(PNP_UDP_1) 		3 CYH A 172
PRO A  98
ASP A  95
 None
 1.01A 4pm5A-5f7oA:
undetectable		 4pm5A-5f7oA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h1u TRANSCRIPTION
INTERMEDIARY FACTOR
1-ALPHA

(Homo sapiens) 		no annotation 3 CYH B 840
PRO B 845
ASP B 827
 None
 0.99A 4pm5A-5h1uB:
undetectable		 4pm5A-5h1uB:
19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hdw F-BOX ONLY PROTEIN 3

(Homo sapiens) 		PF04379
(DUF525) 		3 CYH A 324
PRO A 320
ASP A 283
 None
 0.99A 4pm5A-5hdwA:
undetectable		 4pm5A-5hdwA:
17.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hy7 PUTATIVE PRE-MRNA
SPLICING PROTEIN

(Chaetomium
thermophilum) 		PF03178
(CPSF_A)
PF10433
(MMS1_N) 		3 CYH A 447
PRO A 792
ASP A 422
 None
 0.91A 4pm5A-5hy7A:
undetectable		 4pm5A-5hy7A:
13.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i2t PERIODIC TRYPTOPHAN
PROTEIN 2

(Saccharomyces
cerevisiae) 		PF00400
(WD40) 		3 CYH A 478
PRO A 475
ASP A 517
 None
 0.85A 4pm5A-5i2tA:
undetectable		 4pm5A-5i2tA:
17.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5k8o 5-NITROANTHRANILIC
ACID AMINOHYDROLASE

(Bradyrhizobium
sp.) 		PF01546
(Peptidase_M20)
PF07687
(M20_dimer) 		3 CYH A 156
PRO A  34
ASP A  64
 None
 1.00A 4pm5A-5k8oA:
undetectable		 4pm5A-5k8oA:
22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kyv LUCIFERIN
4-MONOOXYGENASE

(Photinus
pyralis) 		PF00501
(AMP-binding)
PF13193
(AMP-binding_C) 		3 CYH A 216
PRO A  16
ASP A  19
 None
 0.86A 4pm5A-5kyvA:
undetectable		 4pm5A-5kyvA:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lv9 THERMOPHILIC
TRYPTOPHAN
HALOGENASE

(Streptomyces
violaceusniger) 		PF04820
(Trp_halogenase) 		3 CYH A 274
PRO A  93
ASP A 130
 None
 0.88A 4pm5A-5lv9A:
undetectable		 4pm5A-5lv9A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n38 E3 UBIQUITIN-PROTEIN
LIGASE PARKIN,E3
UBIQUITIN-PROTEIN
LIGASE PARKIN

(Homo sapiens) 		PF00240
(ubiquitin)
PF01485
(IBR) 		3 CYH A 238
PRO A 247
ASP A 262
 ZN  A2503 ( 2.3A)
None
None
 0.99A 4pm5A-5n38A:
undetectable		 4pm5A-5n38A:
18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ohs -

(-) 		no annotation 3 CYH A 471
PRO A 572
ASP A 123
 None
 0.96A 4pm5A-5ohsA:
undetectable		 4pm5A-5ohsA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t1q N-ACETYLMURAMOYL-L-A
LANINE AMIDASE
DOMAIN-CONTAINING
PROTEIN
SAOUHSC_02979

(Staphylococcus
aureus) 		PF01832
(Glucosaminidase)
PF05257
(CHAP) 		3 CYH A 513
PRO A 509
ASP A 534
 None
 0.84A 4pm5A-5t1qA:
undetectable		 4pm5A-5t1qA:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vm1 XYLULOKINASE

(Brucella ovis) 		PF00370
(FGGY_N)
PF02782
(FGGY_C) 		3 CYH A 280
PRO A 270
ASP A 179
 None
 0.48A 4pm5A-5vm1A:
undetectable		 4pm5A-5vm1A:
21.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5vpq BETA-LACTAMASE

(Paraburkholderia
phymatum) 		PF13354
(Beta-lactamase2) 		3 CYH A  57
PRO A 156
ASP A 230
 None
None
EDO  A 304 (-3.7A)
 0.49A 4pm5A-5vpqA:
41.4		 4pm5A-5vpqA:
48.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xix ASPARAGINE--TRNA
LIGASE, CYTOPLASMIC

(Homo sapiens) 		no annotation 3 CYH A 342
PRO A 512
ASP A 349
 None
GOL  A 604 ( 4.3A)
None
 1.00A 4pm5A-5xixA:
undetectable		 4pm5A-5xixA:
14.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5y3r DNA-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT

(Homo sapiens) 		PF00454
(PI3_PI4_kinase)
PF02259
(FAT)
PF02260
(FATC)
PF08163
(NUC194) 		3 CYH C2248
PRO C2252
ASP C2208
 None
 0.84A 4pm5A-5y3rC:
undetectable		 4pm5A-5y3rC:
5.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ykn PROBABLE
LYSINE-SPECIFIC
DEMETHYLASE JMJ14

(Arabidopsis
thaliana) 		no annotation 3 CYH A 550
PRO A 537
ASP A 556
 ZN  A 802 (-3.3A)
None
None
 0.94A 4pm5A-5yknA:
undetectable		 4pm5A-5yknA:
15.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ze4 DIHYDROXY-ACID
DEHYDRATASE,
CHLOROPLASTIC

(Arabidopsis
thaliana) 		no annotation 3 CYH A  66
PRO A 137
ASP A 140
 FES  A 601 (-2.3A)
None
MG  A 606 ( 3.0A)
 1.01A 4pm5A-5ze4A:
undetectable		 4pm5A-5ze4A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6aun PLA2G6, IPLA2BETA

(Cricetulus
griseus) 		no annotation 3 CYH A 681
PRO A 684
ASP A 598
 None
 0.95A 4pm5A-6aunA:
undetectable		 4pm5A-6aunA:
17.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cri -

(-) 		no annotation 3 CYH G 400
PRO G 394
ASP G 390
 None
 0.89A 4pm5A-6criG:
undetectable		 4pm5A-6criG:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6en4 SPLICING FACTOR 3B
SUBUNIT 1
SPLICING FACTOR 3B
SUBUNIT 3

(Homo sapiens) 		no annotation 3 CYH C 677
PRO C 718
ASP A 147
 None
 0.72A 4pm5A-6en4C:
undetectable		 4pm5A-6en4C:
14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eoe 78 KDA
GLUCOSE-REGULATED
PROTEIN

(Cricetulus
griseus) 		no annotation 3 CYH A  41
PRO A  63
ASP A 391
 None
None
ADP  A 603 (-3.6A)
 0.89A 4pm5A-6eoeA:
undetectable		 4pm5A-6eoeA:
20.34